Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model
about
Applications of nanotechnology in dermatologyUnderstanding natural herpes simplex virus immunity to inform next-generation vaccine designSingle-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface ProductionAvian influenza: virology, diagnosis and surveillance.Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunityLangerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays.Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicityIntradermal delivery of vaccines: potential benefits and current challenges.Enabling skin vaccination using new delivery technologies.Delivery systems for intradermal vaccinationTransdermal patches: history, development and pharmacology.Delivery of salmon calcitonin using a microneedle patch.Local response to microneedle-based influenza immunization in the skin.The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunizationMicroneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.Microneedles for drug and vaccine deliveryDose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.Stability of influenza vaccine coated onto microneedles.Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum.New routes for allergen immunotherapy.Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in miceMeasles vaccination using a microneedle patchPotent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.Gua Sha, a press-stroke treatment of the skin, boosts the immune response to intradermal vaccination.Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.New directions in immunotherapy.Microneedle patches for vaccine delivery.Advanced materials and nanotechnology for drug delivery.Progress in Psoriasis Therapy via Novel Drug Delivery Systems.Microneedles: an innovative platform for gene delivery.Microneedle patches for vaccination in developing countries.Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy.High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen.Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micro-medical device translation: from mice, rats, rabbits, pigs to humans.
P2860
Q24170384-E9C2DB69-065D-4335-907B-E72B98A2B6BDQ26741484-C791F405-0188-419B-9E25-01414044AB89Q28553947-1E2A254F-4CD9-4F34-A637-A5B914BBAC9AQ30353483-B8E66AF2-61CC-474A-BECC-35BD473F1D8BQ30357830-F0D63546-DC48-474E-886A-B0B0B47497C8Q30426851-B016660B-8C3E-464A-A77D-4A97FD26A2C8Q33563977-D02529B5-9F88-4B68-8E2B-B97D4F61EE38Q33728320-B3FA35CC-4040-4621-9F2F-0EF6EF0CB503Q33916017-FEABD24A-4CC6-48F2-B49B-0839C56351A7Q34436099-5400077F-6060-42D9-8EE7-55EC587CAB72Q34601669-CAB2F494-CBF6-4BD0-B133-2894755259E0Q35126354-CF0EFF51-1D7F-4F24-B245-8EDEFDC97931Q35214379-4A22D364-3A4B-42C0-9885-CE16367A2E52Q35484265-DD3F31DF-3224-446D-B512-7671D68B700FQ35740055-0B53559A-EFDE-41DB-9B4A-4B780EE708CBQ35826992-D594F28D-F999-499E-9171-54D5F2BF8585Q36037373-E575DBB2-48FC-4234-A8E8-4F298C07CAB1Q36077060-EC376B88-BDF9-49CF-BA44-DFDE5DCE40CCQ36164749-7188D99C-A282-430F-8D74-BA4127506EA5Q36175711-84E0DAEE-69A8-4461-A789-CE82E9B5AD41Q36215695-97DF60FE-1F28-44FD-A420-E2DA7DCF19D7Q36616041-C10E9032-EAE5-43C1-BFFA-91F156FAC0B3Q36650284-163F8BF1-BEE1-495D-AFC4-67D7D3E4A315Q36681086-A49DFCF0-AF66-4F2A-AE0B-80BC00DFD687Q36864957-0F503FE2-D138-4C38-A613-317231F4DDE8Q36996938-9DB1257E-908E-4E8B-BAB8-084305B1757EQ36997297-C0C1A75C-4F8F-4124-BD6A-DB8EF700AA85Q37087055-80A36216-E790-4961-83A7-DE4AFFB9683EQ37267223-0F4B4489-A63A-4143-8B0F-2A83F8EBD3C7Q37999873-7255DA50-9B5F-48DB-8B35-4BD1525B7F52Q38073718-57F646EB-C5BC-44D6-A024-29B5299F43D7Q38178693-3091FB1A-3764-4963-83BF-111940E12772Q38180643-FBB8411F-C526-4C72-AEAE-592277687A3FQ38266900-14FB9894-AE6F-4B42-81BA-DCFBEC03BB7EQ38539948-1C9F4E8F-BFAB-41C7-B2CE-23ACA6417980Q38646712-0B8A05B5-8FA0-4545-A571-BD6647C683BCQ41547691-C7A6C723-F055-4D50-AE5A-79E21F921432Q41925081-2A2A5C37-63CD-41CC-8D6A-DBD9FEBEBEC1Q45287028-4D03CABB-32DA-4360-AE26-7F411F30D3D6Q46256773-F2BC92C1-ECFD-4BD5-96F8-04878E94E156
P2860
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent immunity to low doses o ...... skin delivery in a mouse model
@ast
Potent immunity to low doses o ...... skin delivery in a mouse model
@en
Potent immunity to low doses o ...... skin delivery in a mouse model
@nl
type
label
Potent immunity to low doses o ...... skin delivery in a mouse model
@ast
Potent immunity to low doses o ...... skin delivery in a mouse model
@en
Potent immunity to low doses o ...... skin delivery in a mouse model
@nl
prefLabel
Potent immunity to low doses o ...... skin delivery in a mouse model
@ast
Potent immunity to low doses o ...... skin delivery in a mouse model
@en
Potent immunity to low doses o ...... skin delivery in a mouse model
@nl
P2093
P2860
P50
P3181
P1433
P1476
Potent immunity to low doses o ...... skin delivery in a mouse model
@en
P2093
Emily J Fairmaid
Germain J P Fernando
Mark A F Kendall
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0010266
P407
P577
2010-01-01T00:00:00Z